LINEAGE CELL THERAPEUTICS

Serial Number 97794675
Registration 7326101
700

Registration Progress

Application Filed
Feb 14, 2023
Under Examination
Approved for Publication
Dec 26, 2023
Published for Opposition
Dec 26, 2023
Registered
Mar 12, 2024

Trademark Image

LINEAGE CELL THERAPEUTICS

Basic Information

Serial Number
97794675
Registration Number
7326101
Filing Date
February 14, 2023
Registration Date
March 12, 2024
Published for Opposition
December 26, 2023
Drawing Code
3

Status Summary

Current Status
Active
Status Code
700
Status Date
Mar 12, 2024
Registration
Registered
Classes
042

Rights Holder

Lineage Cell Therapeutics, Inc.

03
Address
2173 Salk Avenue, Suite 200
Carlsbad, CA 92008

Ownership History

Lineage Cell Therapeutics, Inc.

Original Applicant
03
Carlsbad, CA

Lineage Cell Therapeutics, Inc.

Owner at Publication
03
Carlsbad, CA

Lineage Cell Therapeutics, Inc.

Original Registrant
03
Carlsbad, CA

Legal Representation

Attorney
Harold Milstein

USPTO Deadlines

Next Deadline
1585 days remaining
Section 8 (6-Year) Declaration Due (Based on registration date 2024-03-12)
Due Date
March 12, 2030
Grace Period Ends
September 12, 2030
Additional deadlines exist. Contact your attorney for complete deadline information.

Application History

14 events
Date Code Type Description Documents
Mar 12, 2024 NRCC E NOTICE OF REGISTRATION CONFIRMATION EMAILED Loading...
Mar 12, 2024 R.PR A REGISTERED-PRINCIPAL REGISTER Loading...
Dec 26, 2023 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Dec 26, 2023 PUBO A PUBLISHED FOR OPPOSITION Loading...
Dec 6, 2023 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Nov 17, 2023 CNSA O APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Nov 17, 2023 XAEC I EXAMINER'S AMENDMENT ENTERED Loading...
Nov 17, 2023 GNEN O NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED Loading...
Nov 17, 2023 GNEA F EXAMINERS AMENDMENT E-MAILED Loading...
Nov 17, 2023 CNEA R EXAMINERS AMENDMENT -WRITTEN Loading...
Nov 13, 2023 DOCK D ASSIGNED TO EXAMINER Loading...
Mar 7, 2023 MDSC E NOTICE OF DESIGN SEARCH CODE E-MAILED Loading...
Mar 4, 2023 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Feb 17, 2023 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 042
Pharmaceutical and biological research and development services in the field of cellular therapies, cell-based tissue regeneration and engineering, extracellular matrix biomaterial, cellular repair technology, cellular replacement therapy, cellular restoration therapy, cellular therapy delivery technology and cell culturing; Providing medical research information in the field of cellular therapies, cell-based tissue regeneration and engineering, extracellular matrix biomaterial, cellular repair technology, cellular replacement therapy, cellular restoration therapy, cellular therapy delivery technology and cell culturing
First Use Anywhere: Jan 23, 2023
First Use in Commerce: Jan 23, 2023

Additional Information

Design Mark
The mark consists of a dark blue horizontal line followed by three light blue horizontal lines followed by five light blue and orange horizontal lines, immediately followed by the stylized word "LINEAGE" in white stacked on top of the stylized words "CELL THERAPEUTICS" in white. The black in the drawing represents background area and is not part of the mark.
Color Claim
The color(s) dark blue, light blue, orange, and white is/are claimed as a feature of the mark.

Classification

International Classes
042

Disclaimers

The following terms have been disclaimed and are not claimed as part of the trademark:
Specific Disclaimer
"CELL THERAPEUTICS"